New Diagnostic Tests: Breakthrough Approaches or Expensive Add-ons?

Richard A. Deyo; Jeffrey J. Jarvik

doi:10.7326/0003-4819-139-11-200312020-00014

New Diagnostic Tests: Breakthrough Approaches or Expensive Add-ons?

Richard A. Deyo, Jeffrey J. Jarvik

Family Medicine

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Gould and colleagues' state-of-the-art meta-analysis on the accuracy of positron emission tomography (PET) scanning for mediastinal staging in patients with non-small-cell lung cancer supports its use. However, the effect of PET scanning on patient outcomes is unknown, which is a major shortcoming of the evidence needed to support its wider use. Improved test sensitivity and specificity alone are not enough.

Original language	English (US)
Pages (from-to)	950-951
Number of pages	2
Journal	Annals of internal medicine
Volume	139
Issue number	11
DOIs	https://doi.org/10.7326/0003-4819-139-11-200312020-00014
State	Published - Dec 2 2003

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/0003-4819-139-11-200312020-00014

Cite this

@article{45897962e1df4149ba5789e81d7fe088,

title = "New Diagnostic Tests: Breakthrough Approaches or Expensive Add-ons?",

abstract = "Gould and colleagues' state-of-the-art meta-analysis on the accuracy of positron emission tomography (PET) scanning for mediastinal staging in patients with non-small-cell lung cancer supports its use. However, the effect of PET scanning on patient outcomes is unknown, which is a major shortcoming of the evidence needed to support its wider use. Improved test sensitivity and specificity alone are not enough.",

author = "Deyo, {Richard A.} and Jarvik, {Jeffrey J.}",

year = "2003",

month = dec,

day = "2",

doi = "10.7326/0003-4819-139-11-200312020-00014",

language = "English (US)",

volume = "139",

pages = "950--951",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "11",

}

TY - JOUR

T1 - New Diagnostic Tests

T2 - Breakthrough Approaches or Expensive Add-ons?

AU - Deyo, Richard A.

AU - Jarvik, Jeffrey J.

PY - 2003/12/2

Y1 - 2003/12/2

N2 - Gould and colleagues' state-of-the-art meta-analysis on the accuracy of positron emission tomography (PET) scanning for mediastinal staging in patients with non-small-cell lung cancer supports its use. However, the effect of PET scanning on patient outcomes is unknown, which is a major shortcoming of the evidence needed to support its wider use. Improved test sensitivity and specificity alone are not enough.

AB - Gould and colleagues' state-of-the-art meta-analysis on the accuracy of positron emission tomography (PET) scanning for mediastinal staging in patients with non-small-cell lung cancer supports its use. However, the effect of PET scanning on patient outcomes is unknown, which is a major shortcoming of the evidence needed to support its wider use. Improved test sensitivity and specificity alone are not enough.

UR - http://www.scopus.com/inward/record.url?scp=1642453776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642453776&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-139-11-200312020-00014

DO - 10.7326/0003-4819-139-11-200312020-00014

M3 - Review article

C2 - 14644898

AN - SCOPUS:1642453776

SN - 0003-4819

VL - 139

SP - 950

EP - 951

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 11

ER -

New Diagnostic Tests: Breakthrough Approaches or Expensive Add-ons?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this